The Tumor Microenvironment
The field of cancer biology and developmental therapeutics is continually evolving as new methodologies are developed and new targets are discovered. Although multiple therapeutics directly target the malignant cells these drugs rarely prevent recurrence of disease or the progression of metastasis. The complex biology of tumors presents challenges in designing treatments that will eliminate the malignant cells as well as the supporting network of vasculature and stroma that allows for the comparison of tumors to developing organs in embryos. In addition to blood vessels and malignant cells, tumors consist of fibroblasts, immune and inflamma…
Mehr
CHF 346.00
Preise inkl. MwSt. und Versandkosten (Portofrei ab CHF 40.00)
V103:
Folgt in ca. 5 Arbeitstagen
Produktdetails
- ISBN: 978-1-4614-2660-8
- EAN: 9781461426608
- Produktnummer: 14087987
- Verlag: Springer New York
- Sprache: Englisch
- Erscheinungsjahr: 2012
- Seitenangabe: 788 S.
- Masse: H23.5 cm x B15.5 cm x D4.1 cm 1'171 g
- Auflage: 2010
- Abbildungen: Paperback
- Gewicht: 1171
Über den Autor
Rebecca Bagley is a senior scientist at Genzyme Corporation and has worked in the biotechnology industry for 20 years with degrees in biology from Wellesley College and Harvard University. Her expertise in drug development spans a wide range of approaches including immunotherapies, gene and protein therapies, and small molecule delivery with publications in journals such as Molecular Cancer Therapeutics, Cancer Research, and Microvascular Research . Her current research focuses on stem cells, tumor vasculature, and target validation.
5 weitere Werke von Rebecca G. (Hrsg.) Bagley:
Bewertungen
Anmelden